$Eli Lilly and Co (LLY.US)$  two late-stage trials evaluatin...

$Eli Lilly and Co(LLY.US)$ two late-stage trials evaluating a 10 mg or 15 mg injection of tirzepatide — the weight-loss drug marketed in the U.S. as Zepbound — reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity